Literature DB >> 15048250

[The expression of E-cadherin-catenin complex in human salivary adenoid cystic carcinoma]

Y Q Wu1, W G Zhang, Z Tian, Z Y Zhang.   

Abstract

OBJECTIVE: The aim of this study was to investigate the expression of the E-cadherin-catenin(E-cad-cat) complex in human salivary adenoid cystic carcinoma(ACC) and determine the effects of E-cad-cat expression on tumor differentiation,metastasis and invasion as well as their clinical significance.
METHODS: The expression of adhesion molecules,which included E-cadherin,alpha-catenin and beta-catenin,in 10 cases of normal salivary glands,50 cases of human salivary ACC was investigated by immunohistochemistry.RESULT:Co-expression of E-cadherin,alpha-catenin and beta-catenin was detected in 29(58%) of the 50 ACC specimens.Positive staining of E-cad-cat complex was detected in 7(39%) of the 18 ACC primary sites which had aggressive phenotype of nerve and vasculature.
CONCLUSION: Strong positive signals of E-cad-cat complex were showed in normal salivary glands,and the down regulation expression was observed in ACC cases,The expression of E-cad-cat complex was associated with a more aggressive phenotype on nerve and vasculature.No association with various histopathologic subtypes was found;Down-regulation of E-cad-cat complex may be associated with canceration of normal salivary glands.

Entities:  

Year:  1999        PMID: 15048250

Source DB:  PubMed          Journal:  Shanghai Kou Qiang Yi Xue        ISSN: 1006-7248


  2 in total

1.  Evaluation of immunohistochemical expression of E-cadherin in pleomorphic adenoma and adenoid cystic carcinoma.

Authors:  Bhavani Nagendra Sangala; Vandana Raghunath; Pratibha Kavle; Anish Gupta; Swati Shrikant Gotmare; Venkata Subhash Andey
Journal:  J Oral Maxillofac Pathol       Date:  2022-03-31

2.  Olanzapine-induced methylation alters cadherin gene families and associated pathways implicated in psychosis.

Authors:  Melkaye G Melka; Christina A Castellani; Nagalingam Rajakumar; Richard O'Reilly; Shiva M Singh
Journal:  BMC Neurosci       Date:  2014-09-29       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.